医学
布洛芬
2019年冠状病毒病(COVID-19)
阿纳基纳
细胞激素风暴
冠状病毒
相伴的
关节炎
痰
炎症
疾病
严重急性呼吸综合征冠状病毒2型(SARS-CoV-2)
类风湿性关节炎
消炎药
羟基氯喹
免疫学
内科学
药理学
传染病(医学专业)
肺结核
病理
作者
Alessandro Giollo,Giovanni Adami,Davide Gatti,Luca Idolazzi,Maurizio Rossini
标识
DOI:10.1136/annrheumdis-2020-217598
摘要
We have read with interest the report by Monti et al 1 concerning the clinical course of coronavirus disease (Covid-19) in patients with chronic inflammatory arthritis. However, we could not find data about the use of non-steroidal anti-inflammatory drugs (NSAID) among their patients.
Whether concomitant NSAID treatment may be harmful or safe in patients with Covid-19 is unknown. However, anti-inflammatory therapies might prevent fatal cytokine storm of Covid-19. Ibuprofen, a commonly prescribed NSAID, was found to reduce interleukin-6 (IL-6) in human tissues,2 and in sputum. …
科研通智能强力驱动
Strongly Powered by AbleSci AI